Home › NDC Lookup › Ingredients › Amivantamab-Vmjw
📦 NDC / package directory — not a drug information page

Amivantamab-Vmjw NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Amivantamab-Vmjw products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

1
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
1
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
AMIVANTAMAB 350 mg/1 2
By dosage form
INJECTION 2
Top labelers
Janssen Biotech, Inc. 2

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
Rybrevant amivantamab-vmjw 350 mg/1 INJECTION Janssen · NDC 57894-0501-01 · J9061 · 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00) 57894-0501-01 — On market View →
Rybrevant amivantamab-vmjw 350 mg/1 INJECTION Janssen · NDC 57894-0501-01 · J9061 · 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00) 57894-0501-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.